Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Garret FitzGerald

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Blood Platelets

Living Beings

Physiology

Platelet Aggregation

Disorders

Oxidative Stress

Procedures

Gas Chromatography-Mass Spectrometry

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
54
Lawson, John
40
Pratico', Domenico
35
Rokach, Joshua
15
Funk, Colin
15
Cheng, Yan
12
Grosser, Tilo
11
Smyth, Emer
11
Violi, Francesco
9
Wang, Miao
9
Yu, Ying
9
Iuliano, Luigi
8
Rudic, Radu Daniel
8
Sheller, James
8
McNamara, Peter
8
Patrono, Carlo

Sign-in to see all Coauthors

Publications

TOP 3
Chang Chih-Tsung; Patel Pranav; Gore Vivek; Song Wen-Liang; Lawson John A; Powell William S; Fitzgerald Garret A; Rokach Joshua
A new approach to the synthesis of polyunsaturated deuterated isoprostanes: total synthesis of d4-5-epi-8,12-iso-iPF3alpha-VI and d4-8,12-iso-iPF3alpha-VI.
Maree Andrew O; Fitzgerald Garret A
A roadmap for the twilight zone: navigating United States cardiovascular career development for international trainees.
Song Wen-Liang; Paschos Georgios; Fries Susanne; Reilly Muredach P; Yu Ying; Rokach Joshua; Chang Chih-Tsung; Patel Pranav; Lawson John A; Fitzgerald Garret A
Novel eicosapentaenoic acid-derived F3-isoprostanes as biomarkers of lipid peroxidation.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Garret FitzGerald (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Chang Chih-Tsung; Patel Pranav; Gore Vivek; Song Wen-Liang; Lawson John A; Powell William S; Fitzgerald Garret A; Rokach Joshua
A new approach to the synthesis of polyunsaturated deuterated isoprostanes: total synthesis of d4-5-epi-8,12-iso-iPF3alpha-VI and d4-8,12-iso-iPF3alpha-VI.
Bioorganic & medicinal chemistry letters 2009;19(23):6755-8.
2009: Maree Andrew O; Fitzgerald Garret A
A roadmap for the twilight zone: navigating United States cardiovascular career development for international trainees.
Circulation 2009;120(15):1542-9.
2009: Song Wen-Liang; Paschos Georgios; Fries Susanne; Reilly Muredach P; Yu Ying; Rokach Joshua; Chang Chih-Tsung; Patel Pranav; Lawson John A; Fitzgerald Garret A
Novel eicosapentaenoic acid-derived F3-isoprostanes as biomarkers of lipid peroxidation.
The Journal of biological chemistry 2009;284(35):23636-43.
2009: Greenbaum Doron C; FitzGerald Garret A
Platelets, pyrexia, and plasmodia.
The New England journal of medicine 2009;361(5):526-8.
2009: Yu Y; Ricciotti E; Grosser T; Fitzgerald G A
The translational therapeutics of prostaglandin inhibition in atherothrombosis.
Journal of thrombosis and haemostasis : JTH 2009;7 Suppl 1():222-6.
2009: Yu Ying; Lucitt Margaret B; Stubbe Jane; Cheng Yan; Friis Ulla G; Hansen Pernille B; Jensen Boye L; Smyth Emer M; FitzGerald Garret A
Prostaglandin F2alpha elevates blood pressure and promotes atherosclerosis.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(19):7985-90.
2009: Wang Dairong; Patel Vickas V; Ricciotti Emanuela; Zhou Rong; Levin Mark D; Gao Ehre; Yu Zhou; Ferrari Victor A; Lu Min Min; Xu Junwang; Zhang Hualei; Hui Yiqun; Cheng Yan; Petrenko Nataliya; Yu Ying; FitzGerald Garret A
Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(18):7548-52.
2009: Smyth Emer M; Grosser Tilo; Wang Miao; Yu Ying; FitzGerald Garret A
Prostanoids in health and disease.
Journal of lipid research 2009;50 Suppl():S423-8.
2009: Baggs Julie E; Price Tom S; DiTacchio Luciano; Panda Satchidananda; Fitzgerald Garret A; Hogenesch John B
Network features of the mammalian circadian clock.
PLoS biology 2009;7(3):e52.
2009: Vardeh Daniel; Wang Dairong; Costigan Michael; Lazarus Michael; Saper Clifford B; Woolf Clifford J; Fitzgerald Garret A; Samad Tarek A
COX2 in CNS neural cells mediates mechanical inflammatory pain hypersensitivity in mice.
The Journal of clinical investigation 2009;119(2):287-94.
2008: Price Tom S; Baggs Julie E; Curtis Anne M; Fitzgerald Garret A; Hogenesch John B
WAVECLOCK: wavelet analysis of circadian oscillation.
Bioinformatics (Oxford, England) 2008;24(23):2794-5.
2008: Parastatidis Ioannis; Thomson Leonor; Burke Anne; Chernysh Irina; Nagaswami Chandrasekaran; Visser Jetze; Stamer Sheryl; Liebler Daniel C; Koliakos George; Heijnen Harry F G; Fitzgerald Garret A; Weisel John W; Ischiropoulos Harry
Fibrinogen beta-chain tyrosine nitration is a prothrombotic risk factor.
The Journal of biological chemistry 2008;283(49):33846-53.
2008: Chang Chih-Tsung; Patel Pranav; Kang Namin; Lawson John A; Song Wen-Liang; Powell William S; FitzGerald Garret A; Rokach Joshua
Eicosapentaenoic-acid-derived isoprostanes: synthesis and discovery of two major isoprostanes.
Bioorganic & medicinal chemistry letters 2008;18(20):5523-7.
2008: FitzGerald Garret A
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA : the journal of the American Medical Association 2008;300(8):900-1; author reply 904-5.
2008: Fitzgerald Garret A
Drugs, industry, and academia.
Science (New York, N.Y.) 2008;320(5883):1563.
2008: Chen Mei; Boilard Eric; Nigrovic Peter A; Clark Patsy; Xu Daigen; Fitzgerald Garret A; Audoly Laurent P; Lee David M
Predominance of cyclooxygenase 1 over cyclooxygenase 2 in the generation of proinflammatory prostaglandins in autoantibody-driven K/BxN serum-transfer arthritis.
Arthritis and rheumatism 2008;58(5):1354-65.
2008: Wang M; Song W-L; Cheng Y; Fitzgerald G A
Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease.
Journal of internal medicine 2008;263(5):500-5.
2008: Lucitt Margaret B; Price Thomas S; Pizarro Angel; Wu Weichen; Yocum Anastasia K; Seiler Christoph; Pack Michael A; Blair Ian A; Fitzgerald Garret A; Grosser Tilo
Analysis of the zebrafish proteome during embryonic development.
Molecular & cellular proteomics : MCP 2008;7(5):981-94.
2008: Ky Bonnie; Burke Anne; Tsimikas Sotirios; Wolfe Megan L; Tadesse Mahlet G; Szapary Philippe O; Witztum Joseph L; FitzGerald Garret A; Rader Daniel J
The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans.
Journal of the American College of Cardiology 2008;51(17):1653-62.
2008: Westgate Elizabeth J; Cheng Yan; Reilly Dermot F; Price Tom S; Walisser Jacqueline A; Bradfield Christopher A; FitzGerald Garret A
Genetic components of the circadian clock regulate thrombogenesis in vivo.
Circulation 2008;117(16):2087-95.
2008: FitzGerald Garret A
Translational therapeutics at the platelet vascular interface. Summary.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(3):s51-2.
2008: FitzGerald Garret A
Translational therapeutics at the platelet vascular interface. Introduction.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(3):s3-4.
2008: Wang Miao; Lee Eric; Song Wenliang; Ricciotti Emanuela; Rader Daniel J; Lawson John A; Puré Ellen; FitzGerald Garret A
Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation.
Circulation 2008;117(10):1302-9.
2008: Kunieda Takeshige; Minamino Tohru; Miura Kentaro; Katsuno Taro; Tateno Kaoru; Miyauchi Hideyuki; Kaneko Shuichi; Bradfield Christopher A; FitzGerald Garret A; Komuro Issei
Reduced nitric oxide causes age-associated impairment of circadian rhythmicity.
Circulation research 2008;102(5):607-14.
2008: Song Wen-Liang; Wang Miao; Ricciotti Emanuela; Fries Susanne; Yu Ying; Grosser Tilo; Reilly Muredach; Lawson John A; FitzGerald Garret A
Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D2 in mice and humans.
The Journal of biological chemistry 2008;283(2):1179-88.
2008: Reilly Dermot F; Curtis Anne M; Cheng Yan; Westgate Elizabeth J; Rudic Radu D; Paschos Georgios; Morris Jacqueline; Ouyang Ming; Thomas Steven A; FitzGerald Garret A
Peripheral circadian clock rhythmicity is retained in the absence of adrenergic signaling.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(1):121-6.
2008: Song Wen-Liang; Lawson John A; Reilly Dermot; Rokach Joshua; Chang Chih-Tsung; Giasson Benoit; FitzGerald Garret A
Neurofurans, novel indices of oxidant stress derived from docosahexaenoic acid.
The Journal of biological chemistry 2008;283(1):6-16.
2008: Keating Brendan J; Tischfield Sam; Murray Sarah S; Bhangale Tushar; Price Thomas S; Glessner Joseph T; Galver Luana; Barrett Jeffrey C; Grant Struan F A; Farlow Deborah N; Chandrupatla Hareesh R; Hansen Mark; Ajmal Saad; Papanicolaou George J; Guo Yiran; Li Mingyao; Derohannessian Stephanie; de Bakker Paul I W; Bailey Swneke D; Montpetit Alexandre; Edmondson Andrew C; Taylor Kent; Gai Xiaowu; Wang Susanna S; Fornage Myriam; Shaikh Tamim; Groop Leif; Boehnke Michael; Hall Alistair S; Hattersley Andrew T; Frackelton Edward; Patterson Nick; Chiang Charleston W K; Kim Cecelia E; Fabsitz Richard R; Ouwehand Willem; Price Alkes L; Munroe Patricia; Caulfield Mark; Drake Thomas; Boerwinkle Eric; Reich David; Whitehead A Stephen; Cappola Thomas P; Samani Nilesh J; Lusis A Jake; Schadt Eric; Wilson James G; Koenig Wolfgang; McCarthy Mark I; Kathiresan Sekar; Gabriel Stacey B; Hakonarson Hakon; Anand Sonia S; Reilly Muredach; Engert James C; Nickerson Deborah A; Rader Daniel J; Hirschhorn Joel N; Fitzgerald Garret A
Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies.
PloS one 2008;3(10):e3583.
2007: Funk Colin D; FitzGerald Garret A
COX-2 inhibitors and cardiovascular risk.
Journal of cardiovascular pharmacology 2007;50(5):470-9.
2007: Jaffar Zeina; Ferrini Maria E; Buford Mary C; Fitzgerald Garret A; Roberts Kevan
Prostaglandin I2-IP signaling blocks allergic pulmonary inflammation by preventing recruitment of CD4+ Th2 cells into the airways in a mouse model of asthma.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(9):6193-203.
2007: Huang Jaou-Chen; Wun Wan-Song A; Goldsby Jennifer S; Egan Karine; FitzGerald Garret A; Wu Kenneth K
Prostacyclin receptor signaling and early embryo development in the mouse.
Human reproduction (Oxford, England) 2007;22(11):2851-6.
2007: Reilly Dermot F; Westgate Elizabeth J; FitzGerald Garret A
Peripheral circadian clocks in the vasculature.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(8):1694-705.
2007: Wada Masayuki; DeLong Cynthia J; Hong Yu H; Rieke Caroline J; Song Inseok; Sidhu Ranjinder S; Yuan Chong; Warnock Mark; Schmaier Alvin H; Yokoyama Chieko; Smyth Emer M; Wilson Stephen J; FitzGerald Garret A; Garavito R Michael; Sui De Xin; Regan John W; Smith William L
Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products.
The Journal of biological chemistry 2007;282(31):22254-66.
2007: FitzGerald Garret A
COX-2 in play at the AHA and the FDA.
Trends in pharmacological sciences 2007;28(7):303-7.
2007: North Trista E; Goessling Wolfram; Walkley Carl R; Lengerke Claudia; Kopani Kamden R; Lord Allegra M; Weber Gerhard J; Bowman Teresa V; Jang Il-Ho; Grosser Tilo; Fitzgerald Garret A; Daley George Q; Orkin Stuart H; Zon Leonard I
Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis.
Nature 2007;447(7147):1007-11.
2007: Chou Wen-Ling; Chuang Lee-Ming; Chou Chi-Chi; Wang Andrew H-J; Lawson John A; FitzGerald Garret A; Chang Zee-Fen
Identification of a novel prostaglandin reductase reveals the involvement of prostaglandin E2 catabolism in regulation of peroxisome proliferator-activated receptor gamma activation.
The Journal of biological chemistry 2007;282(25):18162-72.
2007: García Rodríguez Luis Alberto; Egan Karine; FitzGerald Garret A
Traditional nonsteroidal anti-inflammatory drugs and postmenopausal hormone therapy: a drug-drug interaction?
PLoS medicine 2007;4(5):e157.
2007: Price Thomas S; Lucitt Margaret B; Wu Weichen; Austin David J; Pizarro Angel; Yocum Anastasia K; Blair Ian A; FitzGerald Garret A; Grosser Tilo
EBP, a program for protein identification using multiple tandem mass spectrometry datasets.
Molecular & cellular proteomics : MCP 2007;6(3):527-36.
2007: Zhou Weisong; Blackwell Timothy S; Goleniewska Kasia; O'Neal Jamye F; Fitzgerald Garret A; Lucitt Margaret; Breyer Richard M; Peebles R Stokes
Prostaglandin I2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cells.
Journal of leukocyte biology 2007;81(3):809-17.
2007: Curtis Anne M; Cheng Yan; Kapoor Shiv; Reilly Dermot; Price Tom S; Fitzgerald Garret A
Circadian variation of blood pressure and the vascular response to asynchronous stress.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(9):3450-5.
2007: Zhou Weisong; Hashimoto Koichi; Goleniewska Kasia; O'Neal Jamye F; Ji Shaoquan; Blackwell Timothy S; Fitzgerald Garret A; Egan Karine M; Geraci Mark W; Peebles R Stokes
Prostaglandin I2 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(2):702-10.
2007: Fitzgerald G A
Clinical pharmacology or translational medicine and therapeutics: reinvent or rebrand and expand?
Clinical pharmacology and therapeutics 2007;81(1):19-20.
2007: Yu Ying; Fan Jinjin; Hui Yiqun; Rouzer Carol A; Marnett Lawrence J; Klein-Szanto Andres J; FitzGerald Garret A; Funk Colin D
Targeted cyclooxygenase gene (ptgs) exchange reveals discriminant isoform functionality.
The Journal of biological chemistry 2007;282(2):1498-506.
2007: Song Wen-Liang; Lawson John A; Wang Miao; Zou Helen; FitzGerald Garret A
Noninvasive assessment of the role of cyclooxygenases in cardiovascular health: a detailed HPLC/MS/MS method.
Methods in enzymology 2007;433():51-72.
2006: Cannon Christopher P; Curtis Sean P; FitzGerald Garret A; Krum Henry; Kaur Amarjot; Bolognese James A; Reicin Alise S; Bombardier Claire; Weinblatt Michael E; van der Heijde Désirée; Erdmann Erland; Laine Loren;
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
Lancet 2006;368(9549):1771-81.
2006: Lawson John A; Kim Seongjin; Powell William S; FitzGerald Garret A; Rokach Joshua
Oxidized derivatives of omega-3 fatty acids: identification of IPF3 alpha-VI in human urine.
Journal of lipid research 2006;47(11):2515-24.
2006: Wang Miao; Zukas Alicia M; Hui Yiqun; Ricciotti Emanuela; Puré Ellen; FitzGerald Garret A
Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(39):14507-12.
2006: Lovgren Alysia Kern; Jania Leigh A; Hartney John M; Parsons Kelly K; Audoly Laurent P; Fitzgerald Garret A; Tilley Stephen L; Koller Beverly H
COX-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis.
American journal of physiology. Lung cellular and molecular physiology 2006;291(2):L144-56.
2006: Yu Ying; Fan Jinjin; Chen Xin-Sheng; Wang Dairong; Klein-Szanto Andres J; Campbell Robert L; FitzGerald Garret A; Funk Colin D
Genetic model of selective COX2 inhibition reveals novel heterodimer signaling.
Nature medicine 2006;12(6):699-704.
2006: Cheng Yan; Wang Miao; Yu Ying; Lawson John; Funk Colin D; Fitzgerald Garret A
Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function.
The Journal of clinical investigation 2006;116(5):1391-9.
2006: Jacobo Sheila H; Chang Chih-Tsung; Lee Gue-Jae; Lawson John A; Powell William S; Pratico Domenico; FitzGerald Garret A; Rokach Joshua
Total synthesis of 8,12-iso-iPF3alpha-VI, an EPA-derived isoprostane: stereoselective introduction of the fifth asymmetric center.
The Journal of organic chemistry 2006;71(4):1370-9.
2006: Woon Peng Y; Curtis Anne M; Kaisaki Pamela J; Argoud Karène; Wallace Karin J; Bihoreau Marie-Thérèse; FitzGerald Garret A; Gauguier Dominique
Genomic organization of the rat Clock gene and sequence analysis in inbred rat strains.
Genomics 2006;87(2):208-17.
2006: Ali Ferhana Y; Egan Karine; FitzGerald Garret A; Desvergne Béatrice; Wahli Walter; Bishop-Bailey David; Warner Timothy D; Mitchell Jane A
Role of prostacyclin versus peroxisome proliferator-activated receptor beta receptors in prostacyclin sensing by lung fibroblasts.
American journal of respiratory cell and molecular biology 2006;34(2):242-6.
2006: Fries Susanne; Grosser Tilo; Price Thomas S; Lawson John A; Kapoor Shiv; DeMarco Susan; Pletcher Mathew T; Wiltshire Tim; FitzGerald Garret A
Marked interindividual variability in the response to selective inhibitors of cyclooxygenase-2.
Gastroenterology 2006;130(1):55-64.
2006: Grosser Tilo; Fries Susanne; FitzGerald Garret A
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.
The Journal of clinical investigation 2006;116(1):4-15.
2006: Curtis Anne M; Fitzgerald Garret A
Central and peripheral clocks in cardiovascular and metabolic function.
Annals of medicine 2006;38(8):552-9.
2006: Egan K; FitzGerald G A
Eicosanoids and the vascular endothelium.
Handbook of experimental pharmacology 2006;(176 Pt 1):189-211.
2005: Rudic R Daniel; McNamara Peter; Reilly Dermot; Grosser Tilo; Curtis Anne-Marie; Price Thomas S; Panda Satchidananda; Hogenesch John B; FitzGerald Garret A
Bioinformatic analysis of circadian gene oscillation in mouse aorta.
Circulation 2005;112(17):2716-24.
2005: Fitzgerald Garret A
Opinion: anticipating change in drug development: the emerging era of translational medicine and therapeutics.
Nature reviews. Drug discovery 2005;4(10):815-8.
2005: Francois Helene; Athirakul Krairerk; Howell David; Dash Rajesh; Mao Lan; Kim Hyung-Suk; Rockman Howard A; Fitzgerald Garret A; Koller Beverly H; Coffman Thomas M
Prostacyclin protects against elevated blood pressure and cardiac fibrosis.
Cell metabolism 2005;2(3):201-7.
2005: Westgate Elizabeth J; Fitzgerald Garret A
Pulmonary embolism in a woman taking oral contraceptives and valdecoxib.
PLoS medicine 2005;2(7):e197.
2005: Rudic R Daniel; Brinster Derek; Cheng Yan; Fries Susanne; Song Wen-Liang; Austin Sandra; Coffman Thomas M; FitzGerald Garret A
COX-2-derived prostacyclin modulates vascular remodeling.
Circulation research 2005;96(12):1240-7.
2005: Wang Dairong; Wang Miao; Cheng Yan; Fitzgerald Garret A
Cardiovascular hazard and non-steroidal anti-inflammatory drugs.
Current opinion in pharmacology 2005;5(2):204-10.
2005: Yu Ying; Cheng Yan; Fan Jinjin; Chen Xin-Sheng; Klein-Szanto Andres; Fitzgerald Garret A; Funk Colin D
Differential impact of prostaglandin H synthase 1 knockdown on platelets and parturition.
The Journal of clinical investigation 2005;115(4):986-95.
2005: Kim Seongjin; Powell William S; Lawson John A; Jacobo Sheila H; Pratico Domenico; FitzGerald Garret A; Maxey Kirk; Rokach Joshua
iPF2alpha-III-17,18,19,20-d4: total synthesis and metabolism.
Bioorganic & medicinal chemistry letters 2005;15(6):1613-7.
2005: Kadiiska M B; Gladen B C; Baird D D; Graham L B; Parker C E; Ames B N; Basu S; Fitzgerald G A; Lawson J A; Marnett L J; Morrow J D; Murray D M; Plastaras J; Roberts L J; Rokach J; Shigenaga M K; Sun J; Walter P B; Tomer K B; Barrett J C; Mason R P
Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning.
Free radical biology & medicine 2005;38(6):711-8.
2005: Kadiiska M B; Gladen B C; Baird D D; Germolec D; Graham L B; Parker C E; Nyska A; Wachsman J T; Ames B N; Basu S; Brot N; Fitzgerald G A; Floyd R A; George M; Heinecke J W; Hatch G E; Hensley K; Lawson J A; Marnett L J; Morrow J D; Murray D M; Plastaras J; Roberts L J; Rokach J; Shigenaga M K; Sohal R S; Sun J; Tice R R; Van Thiel D H; Wellner D; Walter P B; Tomer K B; Mason R P; Barrett J C
Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?
Free radical biology & medicine 2005;38(6):698-710.
2005: Pini Barbara; Grosser Tilo; Lawson John A; Price Tom S; Pack Michael A; FitzGerald Garret A
Prostaglandin E synthases in zebrafish.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(2):315-20.
2005: Egan Karine M; Wang Miao; Fries Susanne; Lucitt Margaret B; Zukas Alicia M; Puré Ellen; Lawson John A; FitzGerald Garret A
Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism.
Circulation 2005;111(3):334-42.
2005: Furberg Curt D; Psaty Bruce M; FitzGerald Garret A
Parecoxib, valdecoxib, and cardiovascular risk.
Circulation 2005;111(3):249.
2005: Rudic R Daniel; Curtis Anne M; Cheng Yan; FitzGerald Garret
Peripheral clocks and the regulation of cardiovascular and metabolic function.
Methods in enzymology 2005;393():524-39.
2004: Egan Karine M; Lawson John A; Fries Susanne; Koller Beverley; Rader Daniel J; Smyth Emer M; Fitzgerald Garret A
COX-2-derived prostacyclin confers atheroprotection on female mice.
Science (New York, N.Y.) 2004;306(5703):1954-7.
2004: Hui Yiqun; Cheng Yan; Smalera Isabella; Jian Wenying; Goldhahn Lawrence; Fitzgerald Garret A; Funk Colin D
Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure.
Circulation 2004;110(21):3360-6.
2004: Rudic R Daniel; McNamara Peter; Curtis Anne-Maria; Boston Raymond C; Panda Satchidananda; Hogenesch John B; Fitzgerald Garret A
BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis.
PLoS biology 2004;2(11):e377.
2004: Fitzgerald Garret A
Coxibs and cardiovascular disease.
The New England journal of medicine 2004;351(17):1709-11.
2004: Hashimoto Koichi; Graham Barney S; Geraci Mark W; FitzGerald Garret A; Egan Karine; Zhou Weisong; Goleniewska Kasia; O'Neal Jamye F; Morrow Jason D; Durbin Russell K; Wright Peter F; Collins Robert D; Suzutani Tatsuo; Peebles R Stokes
Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illness.
Journal of virology 2004;78(19):10303-9.
2004: Patrono Carlo; Coller Barry; FitzGerald Garret A; Hirsh Jack; Roth Gerald
Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Chest 2004;126(3 Suppl):234S-264S.
2004: Hennekens Charles H; Schror Karsten; Weisman Steven; FitzGerald Garret A
Terms and conditions: semantic complexity and aspirin resistance.
Circulation 2004;110(12):1706-8.
2004: Sato Trey K; Panda Satchidananda; Miraglia Loren J; Reyes Teresa M; Rudic Radu D; McNamara Peter; Naik Kinnery A; FitzGerald Garret A; Kay Steve A; Hogenesch John B
A functional genomics strategy reveals Rora as a component of the mammalian circadian clock.
Neuron 2004;43(4):527-37.
2004: Fitzgerald Garret A
Prostaglandins: modulators of inflammation and cardiovascular risk.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2004;10(3 Suppl):S12-7.
2004: Praticò Domenico; Rokach Joshua; Lawson John; FitzGerald Garret A
F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases.
Chemistry and physics of lipids 2004;128(1-2):165-71.
2004: Rokach Joshua; Kim Seongjin; Bellone Sophie; Lawson John A; Praticò Domenico; Powell William S; FitzGerald Garret A
Total synthesis of isoprostanes: discovery and quantitation in biological systems.
Chemistry and physics of lipids 2004;128(1-2):35-56.
2004: Kothapalli Devashish; Fuki Ilia; Ali Kamilah; Stewart Sheryl A; Zhao Liang; Yahil Ron; Kwiatkowski David; Hawthorne Elizabeth A; FitzGerald Garret A; Phillips Michael C; Lund-Katz Sissel; Puré Ellen; Rader Daniel J; Assoian Richard K
Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation.
The Journal of clinical investigation 2004;113(4):609-18.
2004: Curtis Anne M; Seo Sang-beom; Westgate Elizabeth J; Rudic Radu Daniel; Smyth Emer M; Chakravarti Debabrata; FitzGerald Garret A; McNamara Peter
Histone acetyltransferase-dependent chromatin remodeling and the vascular clock.
The Journal of biological chemistry 2004;279(8):7091-7.
2003: FitzGerald Garret A
COX-2 and beyond: Approaches to prostaglandin inhibition in human disease.
Nature reviews. Drug discovery 2003;2(11):879-90.
2003: Griendling Kathy K; FitzGerald Garret A
Oxidative stress and cardiovascular injury: Part II: animal and human studies.
Circulation 2003;108(17):2034-40.
2003: Griendling Kathy K; FitzGerald Garret A
Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS.
Circulation 2003;108(16):1912-6.
2003: Bell-Parikh L Chastine; Ide Tomomi; Lawson John A; McNamara Peter; Reilly Muredach; FitzGerald Garret A
Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma.
The Journal of clinical investigation 2003;112(6):945-55.
2003: Burke Anne; Fitzgerald Garret A
Oxidative stress and smoking-induced vascular injury.
Progress in cardiovascular diseases 2003;46(1):79-90.
2003: Ide Tomomi; Egan Karine; Bell-Parikh L Chastine; FitzGerald Garret A
Activation of nuclear receptors by prostaglandins.
Thrombosis research 2003;110(5-6):311-5.
2003: Zhang Zhibing; Vezza Roberta; Plappert Theodore; McNamara Peter; Lawson John A; Austin Sandra; Praticò Domenico; Sutton Martin St-John; FitzGerald Garret A
COX-2-dependent cardiac failure in Gh/tTG transgenic mice.
Circulation research 2003;92(10):1153-61.
2003: Ferro D; Saliola M; Meroni P L; Valesini G; Caroselli C; Praticò D; Fitzgerald G A; Shoenfeld Y; Violi F
Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment.
Journal of thrombosis and haemostasis : JTH 2003;1(3):523-31.
2003: FitzGerald Garret A
Parsing an enigma: the pharmacodynamics of aspirin resistance.
Lancet 2003;361(9357):542-4.
2002: Burke Anne; FitzGerald Garret A; Lucey Michael R
A prospective analysis of oxidative stress and liver transplantation.
Transplantation 2002;74(2):217-21.
2002: Simon Lee S; Smolen Josef S; Abramson Steven B; Appel Gerald; Bombardier Claire; Brater D Craig; Breedveld Ferdinand C; Brune K; Burmester Gerd R; Crofford Leslie J; Dougados Maxime; DuBois Raymond N; Fitzgerald Garret A; Frishman W; García Rodríguez Luis A; Hochberg Marc C; Kalden Joachim R; Laine Loren; Langman Michael J S; Prescott Stephen M; van de Putte Leo B A; Whelton Andrew; White William B; Willaims Gordon H
Controversies in COX-2 selective inhibition.
The Journal of rheumatology 2002;29(7):1501-10.
2002: FitzGerald G A
The choreography of cyclooxygenases in the kidney.
The Journal of clinical investigation 2002;110(1):33-4.
2002: Grosser Tilo; Yusuff Shamila; Cheskis Ellina; Pack Michael A; FitzGerald Garret A
Developmental expression of functional cyclooxygenases in zebrafish.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(12):8418-23.
2002: Rocca Bianca; FitzGerald Garret A
Cyclooxygenases and prostaglandins: shaping up the immune response.
International immunopharmacology 2002;2(5):603-30.
2002: Cheng Yan; Austin Sandra C; Rocca Bianca; Koller Beverly H; Coffman Thomas M; Grosser Tilo; Lawson John A; FitzGerald Garret A
Role of prostacyclin in the cardiovascular response to thromboxane A2.
Science (New York, N.Y.) 2002;296(5567):539-41.
2002: FitzGerald Garret A
Cardiovascular pharmacology of nonselective nonsteroidal anti-inflammatory drugs and coxibs: clinical considerations.
The American journal of cardiology 2002;89(6A):26D-32D.
2002: FitzGerald Garret A
Nonsteroidal anti-inflammatory drugs, coxibs, and cardio-renal physiology: a mechanism-based approach.
The American journal of cardiology 2002;89(6A):1D-2D.
2002: Reilly Muredach; FitzGerald Garret A
Gathering intelligence on antiplatelet drugs: the view from 30 000 feet. When combined with other information overviews lead to conviction.
BMJ (Clinical research ed.) 2002;324(7329):59-60.
2002: McNamara Peter; Lawson John A; Rokach Joshua; FitzGerald Garret A
Isoprostane activation of the nuclear hormone receptor PPAR.
Advances in experimental medicine and biology 2002;507():351-5.
2002: Smyth Emer M; Austin Sandra C; FitzGerald Garret A
Activation-dependent internalization of the human prostacyclin receptor.
Advances in experimental medicine and biology 2002;507():295-301.
2002: Smyth Emer M; FitzGerald Garret A
Human prostacyclin receptor.
Vitamins and hormones 2002;65():149-65.
2001: Patrono C; FitzGerald G A
Oxidant stress in cardiovascular disease: an emerging modality or a disproved theory?
Italian heart journal : official journal of the Italian Federation of Cardiology 2001;2(12):865-6.
2001: Catella-Lawson F; Reilly M P; Kapoor S C; Cucchiara A J; DeMarco S; Tournier B; Vyas S N; FitzGerald G A
Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
The New England journal of medicine 2001;345(25):1809-17.
2001: FitzGerald G A
Bioactive lipids and atherothrombosis.
Haematologica 2001;86(11 Suppl 2):3-7.
2001: FitzGerald G A; Cheng Y; Austin S
COX-2 inhibitors and the cardiovascular system.
Clinical and experimental rheumatology 2001;19(6 Suppl 25):S31-6.
2001: Cyrus T; Tang L X; Rokach J; FitzGerald G A; Praticò D
Lipid peroxidation and platelet activation in murine atherosclerosis.
Circulation 2001;104(16):1940-5.
2001: Al-Abed Y; VanPatten S; Li H; Lawson J A; FitzGerald G A; Manogue K R; Bucala R
Characterization of a novel hemoglobin-glutathione adduct that is elevated in diabetic patients.
Molecular medicine (Cambridge, Mass.) 2001;7(9):619-23.
2001: McNamara P; FitzGerald G A
Smoking-induced vascular disease: a new twist on an old theme.
Circulation research 2001;89(7):563-5.
2001: Regan C L; Levine R J; Baird D D; Ewell M G; Martz K L; Sibai B M; Rokach J; Lawson J A; Fitzgerald G A
No evidence for lipid peroxidation in severe preeclampsia.
American journal of obstetrics and gynecology 2001;185(3):572-8.
2001: FitzGerald G A; Patrono C
The coxibs, selective inhibitors of cyclooxygenase-2.
The New England journal of medicine 2001;345(6):433-42.
2001: Catella-Lawson F; Kapoor S; Moretti D; De Marco S; Vigilante G J; Cucchiara A J; Ramsey K E; Combe S; Rocca B; Theroux P; FitzGerald G A;
Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery disease.
The American journal of cardiology 2001;88(3):236-42.
2001: Praticò D; Lawson J A; Rokach J; FitzGerald G A
The isoprostanes in biology and medicine.
Trends in endocrinology and metabolism: TEM 2001;12(6):243-7.
2001: Narumiya S; FitzGerald G A
Genetic and pharmacological analysis of prostanoid receptor function.
The Journal of clinical investigation 2001;108(1):25-30.
2001: McNamara P; Seo S B; Rudic R D; Sehgal A; Chakravarti D; FitzGerald G A
Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: a humoral mechanism to reset a peripheral clock.
Cell 2001;105(7):877-89.
2001: FitzGerald G A; Loll P
COX in a crystal ball: current status and future promise of prostaglandin research.
The Journal of clinical investigation 2001;107(11):1335-7.
2001: Vezza R; Rokach J; FitzGerald G A
Prostaglandin F(2alpha) receptor-dependent regulation of prostaglandin transport.
Molecular pharmacology 2001;59(6):1506-13.
2001: Cyrus T; Praticò D; Zhao L; Witztum J L; Rader D J; Rokach J; FitzGerald G A; Funk C D
Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice.
Circulation 2001;103(18):2277-82.
2001: Bennett J S; Catella-Lawson F; Rut A R; Vilaire G; Qi W; Kapoor S C; Murphy S; FitzGerald G A
Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in platelets.
Blood 2001;97(10):3093-9.
2001: Mardini I A; FitzGerald G A
Selective inhibitors of cyclooxygenase-2: a growing class of anti-inflammatory drugs.
Molecular interventions 2001;1(1):30-8.
2001: FitzGerald G A; Witztum J L
Oxidative stress. Introduction.
Trends in cardiovascular medicine 2001;11(3-4):91-2.
2001: Praticò D; Tillmann C; Zhang Z B; Li H; FitzGerald G A
Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(6):3358-63.
2001: Fabre J E; Nguyen M; Athirakul K; Coggins K; McNeish J D; Austin S; Parise L K; FitzGerald G A; Coffman T M; Koller B H
Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation.
The Journal of clinical investigation 2001;107(5):603-10.
2001: Meagher E A; Barry O P; Lawson J A; Rokach J; FitzGerald G A
Effects of vitamin E on lipid peroxidation in healthy persons.
JAMA : the journal of the American Medical Association 2001;285(9):1178-82.
2001: Patrono C; Coller B; Dalen J E; FitzGerald G A; Fuster V; Gent M; Hirsh J; Roth G
Platelet-active drugs : the relationships among dose, effectiveness, and side effects.
Chest 2001;119(1 Suppl):39S-63S.
2001: Praticò D; Tangirala R K; Hörkkö S; Witztum J L; Palinski W; FitzGerald G A
Circulating autoantibodies to oxidized cardiolipin correlate with isoprostane F(2alpha)-VI levels and the extent of atherosclerosis in ApoE-deficient mice: modulation by vitamin E.
Blood 2001;97(2):459-64.
2001: Iuliano L; Praticò D; Greco C; Mangieri E; Scibilia G; FitzGerald G A; Violi F
Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA.
Journal of the American College of Cardiology 2001;37(1):76-80.
2001: Whitehead A S; FitzGerald G A
Twenty-first century phox: not yet ready for widespread screening.
Circulation 2001;103(1):7-9.
2001: Tangirala R K; Praticó D; FitzGerald G A; Chun S; Tsukamoto K; Maugeais C; Usher D C; Puré E; Rader D J
Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E.
The Journal of biological chemistry 2001;276(1):261-6.
2000: FitzGerald G A; Austin S; Egan K; Cheng Y; Pratico D
Cyclo-oxygenase products and atherothrombosis.
Annals of medicine 2000;32 Suppl 1():21-6.
2000: Praticò D; Cyrus T; Li H; FitzGerald G A
Endogenous biosynthesis of thromboxane and prostacyclin in 2 distinct murine models of atherosclerosis.
Blood 2000;96(12):3823-6.
2000: Praticò D; Clark C M; Lee V M; Trojanowski J Q; Rokach J; FitzGerald G A
Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity.
Annals of neurology 2000;48(5):809-12.
2000: Smyth E M; Austin S C; Reilly M P; FitzGerald G A
Internalization and sequestration of the human prostacyclin receptor.
The Journal of biological chemistry 2000;275(41):32037-45.
2000: Praticó D; Cheng Y; FitzGerald G A
TP or not TP: primary mediators in a close runoff?
Arteriosclerosis, thrombosis, and vascular biology 2000;20(7):1695-8.
2000: Weinstein E A; Li H; Lawson J A; Rokach J; FitzGerald G A; Axelsen P H
Prothrombinase acceleration by oxidatively damaged phospholipids.
The Journal of biological chemistry 2000;275(30):22925-30.
2000: Meagher E A; FitzGerald G A
Indices of lipid peroxidation in vivo: strengths and limitations.
Free radical biology & medicine 2000;28(12):1745-50.
2000: Audoly L P; Rocca B; Fabre J E; Koller B H; Thomas D; Loeb A L; Coffman T M; FitzGerald G A
Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo.
Circulation 2000;101(24):2833-40.
2000: McAdam B F; Mardini I A; Habib A; Burke A; Lawson J A; Kapoor S; FitzGerald G A
Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation.
The Journal of clinical investigation 2000;105(10):1473-82.
2000: Christofidou-Solomidou M; Pietra G G; Solomides C C; Arguiris E; Harshaw D; Fitzgerald G A; Albelda S M; Muzykantov V R
Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs.
American journal of physiology. Lung cellular and molecular physiology 2000;278(4):L794-805.
2000: Rocca B; Loeb A L; Strauss J F; Vezza R; Habib A; Li H; FitzGerald G A
Directed vascular expression of the thromboxane A2 receptor results in intrauterine growth retardation.
Nature medicine 2000;6(2):219-21.
2000: Burke A; Lawson J A; Meagher E A; Rokach J; FitzGerald G A
Specific analysis in plasma and urine of 2,3-dinor-5, 6-dihydro-isoprostane F(2alpha)-III, a metabolite of isoprostane F(2alpha)-III and an oxidation product of gamma-linolenic acid.
The Journal of biological chemistry 2000;275(4):2499-504.
1999: Li H; Lawson J A; Reilly M; Adiyaman M; Hwang S W; Rokach J; FitzGerald G A
Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(23):13381-6.
1999: Meagher E A; Barry O P; Burke A; Lucey M R; Lawson J A; Rokach J; FitzGerald G A
Alcohol-induced generation of lipid peroxidation products in humans.
The Journal of clinical investigation 1999;104(6):805-13.
1999: Barry O P; FitzGerald G A
Mechanisms of cellular activation by platelet microparticles.
Thrombosis and haemostasis 1999;82(2):794-800.
1999: Lawson J A; Rokach J; FitzGerald G A
Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo.
The Journal of biological chemistry 1999;274(35):24441-4.
1999: Praticó D; Pasin M; Barry O P; Ghiselli A; Sabatino G; Iuliano L; FitzGerald G A; Violi F
Iron-dependent human platelet activation and hydroxyl radical formation: involvement of protein kinase C.
Circulation 1999;99(24):3118-24.
1999: Austin S; FitzGerald G A
Not a mouse stirring: deletion of the EP2 and love's labor's lost.
The Journal of clinical investigation 1999;103(11):1481-2.
1999: Rocca B; Spain L M; Puré E; Langenbach R; Patrono C; FitzGerald G A
Distinct roles of prostaglandin H synthases 1 and 2 in T-cell development.
The Journal of clinical investigation 1999;103(10):1469-77.
1999: Praticò D; Ferro D; Iuliano L; Rokach J; Conti F; Valesini G; FitzGerald G A; Violi F
Ongoing prothrombotic state in patients with antiphospholipid antibodies: a role for increased lipid peroxidation.
Blood 1999;93(10):3401-7.
1999: Ferro D; Basili S; Praticó D; Iuliano L; FitzGerald G A; Violi F
Vitamin E reduces monocyte tissue factor expression in cirrhotic patients.
Blood 1999;93(9):2945-50.
1999: Catella-Lawson F; McAdam B; Morrison B W; Kapoor S; Kujubu D; Antes L; Lasseter K C; Quan H; Gertz B J; FitzGerald G A
Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.
The Journal of pharmacology and experimental therapeutics 1999;289(2):735-41.
1999: Vezza R; Habib A; FitzGerald G A
Differential signaling by the thromboxane receptor isoforms via the novel GTP-binding protein, Gh.
The Journal of biological chemistry 1999;274(18):12774-9.
1999: Rocca B; Spain L M; Ciabattoni G; Patrono C; FitzGerald G A
Differential expression and regulation of cyclooxygenase isozymes in thymic stromal cells.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(8):4589-97.
1999: Barry O P; Kazanietz M G; Praticò D; FitzGerald G A
Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway.
The Journal of biological chemistry 1999;274(11):7545-56.
1999: Al-Abed Y; Mitsuhashi T; Li H; Lawson J A; FitzGerald G A; Founds H; Donnelly T; Cerami A; Ulrich P; Bucala R
Inhibition of advanced glycation endproduct formation by acetaldehyde: role in the cardioprotective effect of ethanol.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(5):2385-90.
1999: Habib A; FitzGerald G A; Maclouf J
Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets.
The Journal of biological chemistry 1999;274(5):2645-51.
1999: McAdam B F; Catella-Lawson F; Mardini I A; Kapoor S; Lawson J A; FitzGerald G A
Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(1):272-7.
1998: Praticò D; Rossi E; Merli M; Riggio O; FitzGerald G A; Violi F
Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patients.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 1998;46(9):430-4.
1998: Reilly M P; Praticò D; Delanty N; DiMinno G; Tremoli E; Rader D; Kapoor S; Rokach J; Lawson J; FitzGerald G A
Increased formation of distinct F2 isoprostanes in hypercholesterolemia.
Circulation 1998;98(25):2822-8.
1998: Praticò D; Basili S; Vieri M; Cordova C; Violi F; Fitzgerald G A
Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress.
American journal of respiratory and critical care medicine 1998;158(6):1709-14.
1998: Praticò D; MY Lee V; Trojanowski J Q; Rokach J; Fitzgerald G A
Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1998;12(15):1777-83.
1998: Lawson J A; Li H; Rokach J; Adiyaman M; Hwang S W; Khanapure S P; FitzGerald G A
Identification of two major F2 isoprostanes, 8,12-iso- and 5-epi-8, 12-iso-isoprostane F2alpha-VI, in human urine.
The Journal of biological chemistry 1998;273(45):29295-301.
1998: Baughman R A; Kapoor S C; Agarwal R K; Kisicki J; Catella-Lawson F; FitzGerald G A
Oral delivery of anticoagulant doses of heparin. A randomized, double-blind, controlled study in humans.
Circulation 1998;98(16):1610-5.
1998: Praticò D; Tangirala R K; Rader D J; Rokach J; FitzGerald G A
Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice.
Nature medicine 1998;4(10):1189-92.
1998: Smyth E M; Li W H; FitzGerald G A
Phosphorylation of the prostacyclin receptor during homologous desensitization. A critical role for protein kinase c.
The Journal of biological chemistry 1998;273(36):23258-66.
1998: Adiyaman M; Lawson J A; Khanapure S P; FitzGerald G A; Rokach J
Total synthesis of 17,17,18,18-d4-iPF2alpha-VI and quantification of iPF2alpha-VI in human urine by gas chromatography/mass spectrometry.
Analytical biochemistry 1998;262(1):45-56.
1998: Kunapuli P; Lawson J A; Rokach J A; Meinkoth J L; FitzGerald G A
Prostaglandin F2alpha (PGF2alpha) and the isoprostane, 8, 12-iso-isoprostane F2alpha-III, induce cardiomyocyte hypertrophy. Differential activation of downstream signaling pathways.
The Journal of biological chemistry 1998;273(35):22442-52.
1998: Rader D J; FitzGerald G A
State of the art: atherosclerosis in a limited edition.
Nature medicine 1998;4(8):899-900.
1998: Regan C L; McAdam B F; McParland P; Boylan P C; FitzGerald G A; Fitzgerald D J
Reduced fetal exposure to aspirin using a novel controlled-release preparation in normotensive and hypertensive pregnancies.
British journal of obstetrics and gynaecology 1998;105(7):732-8.
1998: Barry O P; Praticò D; Savani R C; FitzGerald G A
Modulation of monocyte-endothelial cell interactions by platelet microparticles.
The Journal of clinical investigation 1998;102(1):136-44.
1998: Read J S; Frasch C E; Rich K; Fitzgerald G A; Clemens J D; Pitt J; Pelton S I; Hanson I C; Handelsman E; Diaz C; Fowler M G
The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected women. Women and Infants Transmission Study Group.
The Pediatric infectious disease journal 1998;17(5):391-7.
1998: FitzGerald G A; Charman W N
Interpretation of Thrombosis Prevention Trial.
Lancet 1998;351(9110):1206-7.
1998: Praticò D; Barry O P; Lawson J A; Adiyaman M; Hwang S W; Khanapure S P; Iuliano L; Rokach J; FitzGerald G A
IPF2alpha-I: an index of lipid peroxidation in humans.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(7):3449-54.
1998: Pratico D; Iuliano L; Basili S; Ferro D; Camastra C; Cordova C; FitzGerald G A; Violi F
Enhanced lipid peroxidation in hepatic cirrhosis.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 1998;46(2):51-7.
1998: Reilly M P; Lawson J A; FitzGerald G A
Eicosanoids and isoeicosanoids: indices of cellular function and oxidant stress.
The Journal of nutrition 1998;128(2 Suppl):434S-438S.
1998: Seery L T; Nestor P V; FitzGerald G A
Molecular evolution of the aldo-keto reductase gene superfamily.
Journal of molecular evolution 1998;46(2):139-46.
1997: Rokach J; Khanapure S P; Hwang S W; Adiyaman M; Lawson J A; FitzGerald G A
Nomenclature of isoprostanes: a proposal.
Prostaglandins 1997;54(6):853-73.
1997: Rokach J; Khanapure S P; Hwang S W; Adiyaman M; Lawson J A; FitzGerald G A
The isoprostanes: a perspective.
Prostaglandins 1997;54(6):823-51.
1997: Patrono C; FitzGerald G A
Isoprostanes: potential markers of oxidant stress in atherothrombotic disease.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(11):2309-15.
1997: Reilly M P; Delanty N; Roy L; Rokach J; Callaghan P O; Crean P; Lawson J A; FitzGerald G A
Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans.
Circulation 1997;96(10):3314-20.
1997: Iuliano L; Praticò D; Ferro D; Pittoni V; Valesini G; Lawson J; FitzGerald G A; Violi F
Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies.
Blood 1997;90(10):3931-5.
1997: Kunapuli P; Lawson J A; Rokach J; FitzGerald G A
Functional characterization of the ocular prostaglandin f2alpha (PGF2alpha) receptor. Activation by the isoprostane, 12-iso-PGF2alpha.
The Journal of biological chemistry 1997;272(43):27147-54.
1997: Praticò D; Iuliano L; Mauriello A; Spagnoli L; Lawson J A; Rokach J; Maclouf J; Violi F; FitzGerald G A
Localization of distinct F2-isoprostanes in human atherosclerotic lesions.
The Journal of clinical investigation 1997;100(8):2028-34.
1997: FitzGerald G A; Tigges J; Barry P; Lawson J A
Markers of platelet activation and oxidant stress in atherothrombotic disease.
Thrombosis and haemostasis 1997;78(1):280-4.
1997: Delanty N; Reilly M P; Pratico D; Lawson J A; McCarthy J F; Wood A E; Ohnishi S T; Fitzgerald D J; FitzGerald G A
8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo.
Circulation 1997;95(11):2492-9.
1997: FitzGerald G A
Cigarettes and the wages of sn-2: oxidized species of PAF in smoking hamsters.
The Journal of clinical investigation 1997;99(10):2300-1.
1997: Kinsella B T; O'Mahony D J; Fitzgerald G A
The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha.
The Journal of pharmacology and experimental therapeutics 1997;281(2):957-64.
1997: Barry O P; Pratico D; Lawson J A; FitzGerald G A
Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles.
The Journal of clinical investigation 1997;99(9):2118-27.
1997: FitzGerald G A; Barry P
Dietary factors in thrombosis and hemostasis: summary and conclusions.
The American journal of clinical nutrition 1997;65(5 Suppl):1699S-1701S.
1997: Habib A; Vezza R; Créminon C; Maclouf J; FitzGerald G A
Rapid, agonist-dependent phosphorylation in vivo of human thromboxane receptor isoforms. Minimal involvement of protein kinase C.
The Journal of biological chemistry 1997;272(11):7191-200.
1997: Leo R; Praticò D; Iuliano L; Pulcinelli F M; Ghiselli A; Pignatelli P; Colavita A R; FitzGerald G A; Violi F
Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then reoxygenated.
Circulation 1997;95(4):885-91.
1997: Catella-Lawson F; FitzGerald G A
Confusion in reperfusion. Problems in the clinical development of antithrombotic drugs.
Circulation 1997;95(4):793-5.
1997: Rocca B; FitzGerald G A
Simply read: erythrocytes modulate platelet function. Should we rethink the way we give aspirin?
Circulation 1997;95(1):11-3.
1997: Pratico D; O'Mahony D; Lawson J; Kinsella T; Fitzgerald G A
Cellular activation by thromboxane A2 and 8-EPI-PGF2 alpha.
Advances in experimental medicine and biology 1997;400A():229-33.
1997: Praticò D; Reilly M; Lawson J A; FitzGerald G A
Novel indices of oxidant stress in cardiovascular disease: specific analysis of F2-isoprostanes.
Agents and actions. Supplements 1997;48():25-41.
1996: FitzGerald G A
The human pharmacology of thrombin inhibition.
Coronary artery disease 1996;7(12):911-8.
1996: Smyth E M; Nestor P V; FitzGerald G A
Agonist-dependent phosphorylation of an epitope-tagged human prostacyclin receptor.
The Journal of biological chemistry 1996;271(52):33698-704.
1996: Vezza R; Habib A; Li H; Lawson J A; FitzGerald G A
Regulation of cyclooxygenases by protein kinase C. Evidence against the importance of direct enzyme phosphorylation.
The Journal of biological chemistry 1996;271(47):30028-33.
1996: Reilly M; Delanty N; Lawson J A; FitzGerald G A
Modulation of oxidant stress in vivo in chronic cigarette smokers.
Circulation 1996;94(1):19-25.
1996: Delanty N; Reilly M; Pratico D; FitzGerald D J; Lawson J A; FitzGerald G A
8-Epi PGF2 alpha: specific analysis of an isoeicosanoid as an index of oxidant stress in vivo.
British journal of clinical pharmacology 1996;42(1):15-9.
1996: Praticò D; Smyth E M; Violi F; FitzGerald G A
Local amplification of platelet function by 8-Epi prostaglandin F2alpha is not mediated by thromboxane receptor isoforms.
The Journal of biological chemistry 1996;271(25):14916-24.
1996: Praticó D; FitzGerald G A
Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2.
The Journal of biological chemistry 1996;271(15):8919-24.
1996: Catella-Lawson F; FitzGerald G A
Oxidative stress and platelet activation in diabetes mellitus.
Diabetes research and clinical practice 1996;30 Suppl():13-8.
1995: Wang Z; Ciabattoni G; Créminon C; Lawson J; Fitzgerald G A; Patrono C; Maclouf J
Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man.
The Journal of pharmacology and experimental therapeutics 1995;275(1):94-100.
1995: Catella-Lawson F; FitzGerald G A
Long-term aspirin in the prevention of cardiovascular disorders. Recent developments and variations on a theme.
Drug safety : an international journal of medical toxicology and drug experience 1995;13(2):69-75.
1995: Pratico D; FitzGerald G A
Testosterone and thromboxane. Of muscles, mice, and men.
Circulation 1995;91(11):2694-8.
1995: Pratico D; Lawson J A; FitzGerald G A
Cyclooxygenase-dependent formation of the isoprostane, 8-epi prostaglandin F2 alpha.
The Journal of biological chemistry 1995;270(17):9800-8.
1995: Kinsella B T; O'Mahony D J; Griffin F; FitzGerald G A
Regulated expression of the gene coding for the human thromboxane A2 receptor.
Advances in prostaglandin, thromboxane, and leukotriene research 1995;23():247-9.
1995: Catella F; Reilly M P; Delanty N; Lawson J A; Moran N; Meagher E; FitzGerald G A
Physiological formation of 8-epi-PGF2 alpha in vivo is not affected by cyclooxygenase inhibition.
Advances in prostaglandin, thromboxane, and leukotriene research 1995;23():233-6.
1995: Pratico D; Lawson J A; Fitzgerald G A
Cyclooxygenase dependent formation of 8-iso-prostaglandin F2 alpha by human platelets.
Advances in prostaglandin, thromboxane, and leukotriene research 1995;23():229-31.
1995: Pratico D; Reilly M; Lawson J; Delanty N; FitzGerald G A
Formation of 8-iso-prostaglandin F2 alpha by human platelets.
Agents and actions. Supplements 1995;45():27-31.
1994: Kinsella B T; O'Mahony D J; FitzGerald G A
Phosphorylation and regulated expression of the human thromboxane A2 receptor.
The Journal of biological chemistry 1994;269(47):29914-9.
1994: Pratico D; Lawson J A; Fitzgerald G A
Cyclooxygenase-dependent formation of the isoprostane 8-epi prostaglandin F2 alpha.
Annals of the New York Academy of Sciences 1994;744():139-45.
1994: Ernst M; Liebenauer L L; King A C; Fitzgerald G A; Cohen R M; Zametkin A J
Reduced brain metabolism in hyperactive girls.
Journal of the American Academy of Child and Adolescent Psychiatry 1994;33(6):858-68.
1994: Nordøy A; Hatcher L; Goodnight S; Fitzgerald G A; Conner W E
Effects of dietary fat content, saturated fatty acids, and fish oil on eicosanoid production and hemostatic parameters in normal men.
The Journal of laboratory and clinical medicine 1994;123(6):914-20.
1994: Dworski R; Fitzgerald G A; Oates J A; Sheller J R
Effect of oral prednisone on airway inflammatory mediators in atopic asthma.
American journal of respiratory and critical care medicine 1994;149(4 Pt 1):953-9.
1994: Kinsella B T; O'Mahony D; Lawson J A; Pratico D; Fitzgerald G A
Cellular activation of thromboxane receptors.
Annals of the New York Academy of Sciences 1994;714():270-8.
1994: Fitzgerald G A; Meagher E A
Antiplatelet drugs.
European journal of clinical investigation 1994;24 Suppl 1():46-9.
1994: Ernst M; Zametkin A J; Matochik J A; Liebenauer L; Fitzgerald G A; Cohen R M
Effects of intravenous dextroamphetamine on brain metabolism in adults with attention-deficit hyperactivity disorder (ADHD). Preliminary findings.
Psychopharmacology bulletin 1994;30(2):219-25.
1994: Murphy R C; FitzGerald G A
Current approaches to estimation of eicosanoid formation in vivo.
Advances in prostaglandin, thromboxane, and leukotriene research 1994;22():341-8.
1993: Funk C D; Furci L; FitzGerald G A; Grygorczyk R; Rochette C; Bayne M A; Abramovitz M; Adam M; Metters K M
Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype.
The Journal of biological chemistry 1993;268(35):26767-72.
1993: Reilly M; Fitzgerald G A
Cellular activation by thromboxane A2 and other eicosanoids.
European heart journal 1993;14 Suppl K():88-93.
1993: Charman W N; Charman S A; Monkhouse D C; Frisbee S E; Lockhart E A; Weisman S; Fitzgerald G A
Biopharmaceutical characterisation of a low-dose (75 mg) controlled-release aspirin formulation.
British journal of clinical pharmacology 1993;36(5):470-3.
1993: Funk C D; Furci L; Moran N; Fitzgerald G A
Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites.
Molecular pharmacology 1993;44(5):934-9.
1993: Benowitz N L; Fitzgerald G A; Wilson M; Zhang Q
Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking.
Journal of the American College of Cardiology 1993;22(4):1159-67.
1993: Meagher E A; FitzGerald G A
Disordered eicosanoid formation in pregnancy-induced hypertension.
Circulation 1993;88(3):1324-33.
1993: Zametkin A J; Liebenauer L L; Fitzgerald G A; King A C; Minkunas D V; Herscovitch P; Yamada E M; Cohen R M
Brain metabolism in teenagers with attention-deficit hyperactivity disorder.
Archives of general psychiatry 1993;50(5):333-40.
1993: Sørensen J D; Olsen S F; Pedersen A K; Boris J; Secher N J; FitzGerald G A
Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production.
American journal of obstetrics and gynecology 1993;168(3 Pt 1):915-22.
1993: Harker L A; Kelly A B; Hanson S R; Krupski W; Bass A; Osterud B; FitzGerald G A; Goodnight S H; Connor W E
Interruption of vascular thrombus formation and vascular lesion formation by dietary n-3 fatty acids in fish oil in nonhuman primates.
Circulation 1993;87(3):1017-29.
1992: Goodnight S H; Cairns J A; Fisher M; FitzGerald G A
Assessment of the therapeutic use of n-3 fatty acids in vascular disease and thrombosis.
Chest 1992;102(4 Suppl):374S-384S.
1992: FitzGerald G A; Shipp E
Antiplatelet and anticoagulant drugs in coronary vascular disease.
Annals of epidemiology 1992;2(4):529-42.
1992: Remuzzi G; FitzGerald G A; Patrono C
Thromboxane synthesis and action within the kidney.
Kidney international 1992;41(6):1483-93.
1992: Funk C D; Funk L B; FitzGerald G A; Samuelsson B
Characterization of human 12-lipoxygenase genes.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(9):3962-6.
1992: Kunitada S; FitzGerald G A; Fitzgerald D J
Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction.
Blood 1992;79(6):1420-7.
1992: Kerins D M; Roy L; Kunitada S; Adedoyin A; FitzGerald G A; Fitzgerald D J
Pharmacokinetics of tissue-type plasminogen activator during acute myocardial infarction in men. Effect of a prostacyclin analogue.
Circulation 1992;85(2):526-32.
1992: Knapp H R; Sladek K; Fitzgerald G A
Increased excretion of leukotriene E4 during aspirin-induced asthma.
The Journal of laboratory and clinical medicine 1992;119(1):48-51.
1992: Dworski R; FitzGerald G A; Sheller J R
Thromboxane synthase inhibition in allergen challenged sheep lung: effect on eicosanoid synthesis.
Eicosanoids 1992;5(1):35-7.
1991: FitzGerald G A; Lupinetti M; Charman S A; Charman W N
Presystemic acetylation of platelets by aspirin: reduction in rate of drug delivery to improve biochemical selectivity for thromboxane A2.
The Journal of pharmacology and experimental therapeutics 1991;259(3):1043-9.
1991: Fitzgerald D J; Hanson M; FitzGerald G A
Systemic lysis protects against the effects of platelet activation during coronary thrombolysis.
The Journal of clinical investigation 1991;88(5):1589-95.
1991: Clarke R J; Mayo G; Price P; FitzGerald G A
Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
The New England journal of medicine 1991;325(16):1137-41.
1991: FitzGerald G A
Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists.
The American journal of cardiology 1991;68(7):11B-15B.
1991: Braden G A; Knapp H R; FitzGerald G A
Suppression of eicosanoid biosynthesis during coronary angioplasty by fish oil and aspirin.
Circulation 1991;84(2):679-85.
1991: Funk C D; FitzGerald G A
Eicosanoid forming enzyme mRNA in human tissues. Analysis by quantitative polymerase chain reaction.
The Journal of biological chemistry 1991;266(19):12508-13.
1991: Furci L; Fitzgerald D J; Fitzgerald G A
Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
The Journal of pharmacology and experimental therapeutics 1991;258(1):74-81.
1991: Funk C D; Funk L B; Kennedy M E; Pong A S; Fitzgerald G A
Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1991;5(9):2304-12.
1991: Clarke R J; Mayo G; FitzGerald G A; Fitzgerald D J
Combined administration of aspirin and a specific thrombin inhibitor in man.
Circulation 1991;83(5):1510-8.
1991: Kerins D M; FitzGerald G A
The current role of platelet-active drugs in ischaemic heart disease.
Drugs 1991;41(5):665-71.
1991: Kerins D M; Shuh M; Kunitada S; Fitzgerald G A; Fitzgerald D J
A prostacyclin analog impairs the response to tissue-type plasminogen activator during coronary thrombolysis: evidence for a pharmacokinetic interaction.
The Journal of pharmacology and experimental therapeutics 1991;257(1):487-92.
1991: Kerins D M; Murray R; FitzGerald G A
Prostacyclin and prostaglandin E1: molecular mechanisms and therapeutic utility.
Progress in hemostasis and thrombosis 1991;10():307-37.
1991: Sladek K; Sheller J R; FitzGerald G A; Morrow J D; Roberts L J
Formation of PGD2 after allergen inhalation in atopic asthmatics.
Advances in prostaglandin, thromboxane, and leukotriene research 1991;21A():433-6.
1991: Funk C D; Furci L; FitzGerald G A
Polymerase chain reaction cloning and expression of eicosanoid metabolizing enzymes from blood cells.
Advances in prostaglandin, thromboxane, and leukotriene research 1991;21A():33-6.
1991: FitzGerald G A; Murray R; Moran N; Funk C; Charman W; Clarke R; Furci L; Fitzgerald D J
Mechanisms of eicosanoid action.
Advances in prostaglandin, thromboxane, and leukotriene research 1991;21B():577-81.
1991: Cotton R B; Haywood J L; FitzGerald G A
Symptomatic patent ductus arteriosus following prophylactic indomethacin. A clinical and biochemical appraisal.
Biology of the neonate 1991;60(5):273-82.
1991: Catella F; Lawson J; Braden G; Fitzgerald D J; Shipp E; FitzGerald G A
Biosynthesis of P450 products of arachidonic acid in humans: increased formation in cardiovascular disease.
Advances in prostaglandin, thromboxane, and leukotriene research 1991;21A():193-6.
1990: Murray R; Shipp E; FitzGerald G A
Prostaglandin endoperoxide/thromboxane A2 receptor desensitization. Cross-talk with adenylate cyclase in human platelets.
The Journal of biological chemistry 1990;265(35):21670-5.
1990: Lellouche F; Fradin A; Fitzgerald G; Maclouf J
Enzyme immunoassay measurement of the urinary metabolites of thromboxane A2 and prostacyclin.
Prostaglandins 1990;40(3):297-310.
1990: Sebaldt R J; Sheller J R; Oates J A; Roberts L J; FitzGerald G A
Inhibition of eicosanoid biosynthesis by glucocorticoids in humans.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(18):6974-8.
1990: Funk C D; Furci L; FitzGerald G A
Molecular cloning, primary structure, and expression of the human platelet/erythroleukemia cell 12-lipoxygenase.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(15):5638-42.
1990: Catella F; Lawson J A; Fitzgerald D J; FitzGerald G A
Endogenous biosynthesis of arachidonic acid epoxides in humans: increased formation in pregnancy-induced hypertension.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(15):5893-7.
1990: FitzGerald G A
Ticlopidine in unstable angina. A more expensive aspirin?
Circulation 1990;82(1):296-8.
1990: Braden G A; Knapp H R; Fitzgerald D J; FitzGerald G A
Dietary fish oil accelerates the response to coronary thrombolysis with tissue-type plasminogen activator. Evidence for a modest platelet inhibitory effect in vivo.
Circulation 1990;82(1):178-87.
1990: Sladek K; Dworski R; Fitzgerald G A; Buitkus K L; Block F J; Marney S R; Sheller J R
Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin.
The American review of respiratory disease 1990;141(6):1441-5.
1990: Takahara K; Murray R; FitzGerald G A; Fitzgerald D J
The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems.
The Journal of biological chemistry 1990;265(12):6836-44.
1990: Fitzgerald D J; Rocki W; Murray R; Mayo G; FitzGerald G A
Thromboxane A2 synthesis in pregnancy-induced hypertension.
Lancet 1990;335(8692):751-4.
1990: Murray J J; Nowak J; Oates J A; FitzGerald G A
Platelet-vessel wall interactions in individuals who smoke cigarettes.
Advances in experimental medicine and biology 1990;273():189-98.
1990: Catella F; FitzGerald G A
Measurement of thromboxane metabolites by gas chromatography-mass spectrometry.
Methods in enzymology 1990;187():42-50.
1990: Funk C D; Furci L; Fitzgerald G A
Molecular cloning of the human platelet 12-lipoxygenase.
Transactions of the Association of American Physicians 1990;103():180-6.
1989: Kerins D M; Roy L; FitzGerald G A; Fitzgerald D J
Platelet and vascular function during coronary thrombolysis with tissue-type plasminogen activator.
Circulation 1989;80(6):1718-25.
1989: Lupinetti M D; Sheller J R; Catella F; Fitzgerald G A
Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation.
The American review of respiratory disease 1989;140(4):932-5.
1989: Fitzgerald D J; Fitzgerald G A
Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(19):7585-9.
1989: Murray R; Furci L; FitzGerald G A
Induction of prostacyclin receptor expression in human erythroleukemia cells.
FEBS letters 1989;255(1):172-4.
1989: Benigni A; Chiabrando C; Perico N; Fanelli R; Patrono C; FitzGerald G A; Remuzzi G
Renal metabolism and urinary excretion of thromboxane B2 in the rat.
The American journal of physiology 1989;257(1 Pt 2):F77-85.
1989: Fitzgerald D J; Wright F; FitzGerald G A
Increased thromboxane biosynthesis during coronary thrombolysis. Evidence that platelet activation and thromboxane A2 modulate the response to tissue-type plasminogen activator in vivo.
Circulation research 1989;65(1):83-94.
1989: Knapp H R; FitzGerald G A
The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acid supplements in essential hypertension.
The New England journal of medicine 1989;320(16):1037-43.
1989: Goodnight S H; Fisher M; FitzGerald G A; Levine P H
Assessment of the therapeutic use of dietary fish oil in atherosclerotic vascular disease and thrombosis.
Chest 1989;95(2 Suppl):19S-25S.
1989: Nowak J; FitzGerald G A
Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man.
The Journal of clinical investigation 1989;83(2):380-5.
1989: Murray R; FitzGerald G A
Regulation of thromboxane receptor activation in human platelets.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(1):124-8.
1989: Dworski R; Sheller J R; Wickersham N E; Oates J A; Brigham K L; Roberts L J; Fitzgerald G A
Allergen-stimulated release of mediators into sheep bronchoalveolar lavage fluid. Effect of cyclooxygenase inhibition.
The American review of respiratory disease 1989;139(1):46-51.
1989: FitzGerald G A; Mayo G; Price P; Takahara K
Aspirin in cardiovascular disease; biochemical pharmacology and clinical trials.
Progress in clinical and biological research 1989;301():97-106.
1989: Fitzgerald G A; Braden G; Fitzgerald D J; Knapp H R
Fish oils in cardiovascular disease.
Journal of internal medicine. Supplement 1989;731():25-9.
1989: FitzGerald G A; Murray R; Price P; Catella F
The molecular, biochemical and human pharmacology of thromboxane A2 in renal disease.
Advances in experimental medicine and biology 1989;259():325-60.
1988: Fitzgerald D J; Fragetta J; FitzGerald G A
Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis.
The Journal of clinical investigation 1988;82(5):1708-13.
1988: Reilly I A; Knapp H R; Fitzgerald G A
Leukotriene B4 synthesis and neutrophil chemotaxis in chronic granulocytic leukaemia.
Journal of clinical pathology 1988;41(11):1163-7.
1988: Dworski R; Wendelborn D F; Sheller J R; FitzGerald G A; Roberts L J
Prostaglandins in Ascaris antigen.
The Journal of allergy and clinical immunology 1988;82(3 Pt 1):484.
1988: Oates J A; FitzGerald G A; Branch R A; Jackson E K; Knapp H R; Roberts L J
Clinical implications of prostaglandin and thromboxane A2 formation (2).
The New England journal of medicine 1988;319(12):761-7.
1988: Oates J A; FitzGerald G A; Branch R A; Jackson E K; Knapp H R; Roberts L J
Clinical implications of prostaglandin and thromboxane A2 formation (1).
The New England journal of medicine 1988;319(11):689-98.
1988: Wennmalm A; Fitzgerald G A
Excretion of prostacyclin and thromboxane A2 metabolites during leg exercise in humans.
The American journal of physiology 1988;255(1 Pt 2):H15-8.
1988: Alessandrini P; McRae J; Feman S; FitzGerald G A
Thromboxane biosynthesis and platelet function in type I diabetes mellitus.
The New England journal of medicine 1988;319(4):208-12.
1988: Wennmalm A; Edlund A; Sevastik B; FitzGerald G A
Excretion of thromboxane A2 and prostacyclin metabolites during treadmill exercise in patients with intermittent claudication.
Clinical physiology (Oxford, England) 1988;8(3):243-53.
1988: Knapp H R; Healy C; Lawson J; FitzGerald G A
Effects of low-dose aspirin on endogenous eicosanoid formation in normal and atherosclerotic men.
Thrombosis research 1988;50(3):377-86.
1988: Jackson E K; Goto F; Uderman H D; Workman R J; Herzer W A; FitzGerald G A; Branch R A
Effects of thromboxane synthase inhibitors on renal function.
Naunyn-Schmiedeberg's archives of pharmacology 1988;337(2):183-90.
1988: Reilly I A; FitzGerald G A
Aspirin in cardiovascular disease.
Drugs 1988;35(2):154-76.
1988: Kühl P G; Bolds J M; Loyd J E; Snapper J R; FitzGerald G A
Thromboxane receptor-mediated bronchial and hemodynamic responses in ovine endotoxemia.
The American journal of physiology 1988;254(2 Pt 2):R310-9.
1988: Harold J G; Siegel R J; FitzGerald G A; Satoh P; Fishbein M C
Differential prostacyclin production by human umbilical vasculature.
Archives of pathology & laboratory medicine 1988;112(1):43-6.
1988: FitzGerald G A; Oates J A; Nowak J
Cigarette smoking and hemostatic function.
American heart journal 1988;115(1 Pt 2):267-71.
1988: Fitzgerald D J; Catella F; Roy L; FitzGerald G A
Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction.
Circulation 1988;77(1):142-50.
1987: Catella F; FitzGerald G A
Paired analysis of urinary thromboxane B2 metabolites in humans.
Thrombosis research 1987;47(6):647-56.
1987: Fisher K L; FitzGerald G A; Lawn R M
Two polymorphisms in the human lipoprotein lipase (LPL) gene.
Nucleic acids research 1987;15(18):7657.
1987: Fitzgerald D J; Mayo G; Catella F; Entman S S; FitzGerald G A
Increased thromboxane biosynthesis in normal pregnancy is mainly derived from platelets.
American journal of obstetrics and gynecology 1987;157(2):325-30.
1987: Nowak J; Murray J J; Oates J A; FitzGerald G A
Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes.
Circulation 1987;76(1):6-14.
1987: FitzGerald G A
Dipyridamole.
The New England journal of medicine 1987;316(20):1247-57.
1987: Fitzgerald D J; Entman S S; Mulloy K; FitzGerald G A
Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension.
Circulation 1987;75(5):956-63.
1987: Wennmalm M; FitzGerald G A; Wennmalm A
Prostacyclin as neuromodulator in the sympathetically stimulated rabbit heart.
Prostaglandins 1987;33(5):675-91.
1987: Ciabattoni G; Maclouf J; Catella F; FitzGerald G A; Patrono C
Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine.
Biochimica et biophysica acta 1987;918(3):293-7.
1987: Nowak J; Wennmalm M; Edlund A; Wennmalm A; Fitzgerald G A
Vascular effects of infused adenosine are not mediated by prostacyclin release in humans.
The American journal of physiology 1987;252(3 Pt 2):H598-604.
1987: Fitzgerald G A; Catella F; Oates J A
Eicosanoid biosynthesis in human cardiovascular disease.
Human pathology 1987;18(3):248-52.
1987: Reilly I A; FitzGerald G A
Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs.
Blood 1987;69(1):180-6.
1987: FitzGerald G A; Healy C; Daugherty J
Thromboxane A2 biosynthesis in human disease.
Federation proceedings 1987;46(1):154-8.
1987: Alessandrini P; McRae J R; Feman S S; FitzGerald G A
Eicosanoid biosynthesis in human diabetes mellitus.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17B():682-5.
1987: Catella F; Lawson J A; Fitzgerald D J; FitzGerald G A
Analysis of multiple thromboxane metabolites in plasma and urine.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17B():611-4.
1987: Ciabattoni G; Boss A H; Daffonchio L; Daugherty J; FitzGerald G A; Catella F; Dray F; Patrono C
Radioimmunoassay measurement of 2,3-dinor metabolites of prostacyclin and thromboxane in human urine.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17B():598-602.
1987: Fitzgerald D J; Fragetta J; Fenelon L C; FitzGerald G A
Thromboxane synthase inhibition and thromboxane/endoperoxide receptor antagonism in a chronic canine model of coronary thrombosis.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17A():496-500.
1987: Kühl P G; Bolds J M; Loyd J E; FitzGerald G A
Thromboxane receptor mediated vascular and airway changes in the presence of increased thromboxane biosynthesis in sheep endotoxemia.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17A():487-90.
1987: Edlund A; FitzGerald G A; Sevastik B; Wennmalm A
Leg exercise increases prostacyclin synthesis without activating platelets in both healthy and atherosclerotic humans.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17A():447-9.
1987: Nowak J; FitzGerald G A
In vivo formation of prostacyclin and thromboxane A2 at the site of platelet-vascular interaction in humans.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17A():208-11.
1987: Nowak J; Murray J J; FitzGerald G A; Wehr C J; Hammon J W; Oates J A
Eicosanoids and sudden cardiac death.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17A():20-4.
1987: FitzGerald G A; Fitzgerald D J; Lawson J A; Murray R
Thromboxane biosynthesis and antagonism in humans.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17A():199-203.
1986: Fitzgerald D J; Roy L; Catella F; FitzGerald G A
Platelet activation in unstable coronary disease.
The New England journal of medicine 1986;315(16):983-9.
1986: Catella F; Healy D; Lawson J A; FitzGerald G A
11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(16):5861-5.
1986: Catella F; Nowak J; Fitzgerald G A
Measurement of renal and non-renal eicosanoid synthesis.
The American journal of medicine 1986;81(2B):23-9.
1986: Kuehl P G; Cotton R B; FitzGerald G A
Systemic production of prostacyclin and thromboxane A2 does not correlate with patency of the ductus arteriosus in very low birth weight infants.
The Journal of pediatrics 1986;108(6):977-82.
1986: Reilly I A; Doran J B; Smith B; FitzGerald G A
Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase.
Circulation 1986;73(6):1300-9.
1986: Lawson J A; Patrono C; Ciabattoni G; Fitzgerald G A
Long-lived enzymatic metabolites of thromboxane B2 in the human circulation.
Analytical biochemistry 1986;155(1):198-205.
1986: Reilly I A; Roy L; Fitzgerald G A
Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon.
British medical journal (Clinical research ed.) 1986;292(6527):1037-9.
1986: Knapp H R; Reilly I A; Alessandrini P; FitzGerald G A
In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis.
The New England journal of medicine 1986;314(15):937-42.
1986: Patrono C; Ciabattoni G; Pugliese F; Pierucci A; Blair I A; FitzGerald G A
Estimated rate of thromboxane secretion into the circulation of normal humans.
The Journal of clinical investigation 1986;77(2):590-4.
1986: Reilly I A; FitzGerald G A
Eicosenoid biosynthesis and platelet function with advancing age.
Thrombosis research 1986;41(4):545-54.
1986: Fitzgerald D J; Doran J; Jackson E; FitzGerald G A
Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.
The Journal of clinical investigation 1986;77(2):496-502.
1985: FitzGerald G A; Reilly I A; Pedersen A K
The biochemical pharmacology of thromboxane synthase inhibition in man.
Circulation 1985;72(6):1194-201.
1985: Pedersen A K; FitzGerald G A
The human pharmacology of platelet inhibition: pharmacokinetics relevant to drug action.
Circulation 1985;72(6):1164-76.
1985: Lawson J A; Brash A R; Doran J; FitzGerald G A
Measurement of urinary 2,3-dinor-thromboxane B2 and thromboxane B2 using bonded-phase phenylboronic acid columns and capillary gas chromatography--negative-ion chemical ionization mass spectrometry.
Analytical biochemistry 1985;150(2):463-70.
1985: Roy L; Knapp H R; Robertson R M; FitzGerald G A
Endogenous biosynthesis of prostacyclin during cardiac catheterization and angiography in man.
Circulation 1985;71(3):434-40.
1985: Pedersen A K; FitzGerald G A
Preparation and analysis of deuterium-labeled aspirin: application to pharmacokinetic studies.
Journal of pharmaceutical sciences 1985;74(2):188-92.
1985: Pedersen A K; FitzGerald G A
Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosing.
Clinical pharmacology and therapeutics 1985;37(1):36-42.
1985: Goldberg M R; Robertson D; FitzGerald G A
Prostacyclin biosynthesis and platelet function in autonomic dysfunction.
Neurology 1985;35(1):120-3.
1985: Blair I A; Brash A R; Daugherty J; FitzGerald G A
Quantitative analysis of leukotriene B4 in human serum.
Advances in prostaglandin, thromboxane, and leukotriene research 1985;15():61-5.
1985: FitzGerald G A; Lawson J; Blair I A; Brash A R
Analysis of urinary metabolites of thromboxane and prostacyclin by negative-ion chemical-ionization gas chromatography/mass spectrometry.
Advances in prostaglandin, thromboxane, and leukotriene research 1985;15():87-90.
1984: Pedersen A K; FitzGerald G A
Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase.
The New England journal of medicine 1984;311(19):1206-11.
1984: Fitzgerald D J; Roy L; Robertson R M; FitzGerald G A
The effects of organic nitrates on prostacyclin biosynthesis and platelet function in humans.
Circulation 1984;70(2):297-302.
1984: FitzGerald G A; Fitzgerald D J
Biosynthesis of thromboxane A2 in renovascular hypertension.
JAMA : the journal of the American Medical Association 1984;251(23):3121-2.
1984: FitzGerald G A; Oates J A
Selective and nonselective inhibition of thromboxane formation.
Clinical pharmacology and therapeutics 1984;35(5):633-40.
1984: Knapp H R; Fitzgerald G A
Hypertensive crisis in prazosin-treated pheochromocytoma.
Southern medical journal 1984;77(4):535-6.
1984: FitzGerald G A; Smith B; Pedersen A K; Brash A R
Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation.
The New England journal of medicine 1984;310(17):1065-8.
1984: FitzGerald G A
Peripheral presynaptic adrenoreceptor regulation of norepinephrine release in humans.
Federation proceedings 1984;43(5):1379-81.
1984: Watson M L; Goodman R P; Gill J R; Branch R A; Brash A R; Fitzgerald G A
Endogenous prostacyclin synthesis is decreased during activation of the renin-angiotensin system in man.
The Journal of clinical endocrinology and metabolism 1984;58(2):304-8.
1984: Pedersen A K; Watson M L; FitzGerald G A
Inhibition of thromboxane biosynthesis in serum: limitations of the measurement of immunoreactive 6-keto-PGF1 alpha.
Thrombosis research 1984;33(1):99-103.
1984: Oates J A; Brash A; Fitzgerald G
Comparison of the effects of selective inhibition of thromboxane synthase with those of inhibition of the cyclooxygenase enzyme in man.
Transactions of the American Clinical and Climatological Association 1984;95():157-62.
1983: FitzGerald G A; Brash A R; Oates J A; Pedersen A K
Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man.
The Journal of clinical investigation 1983;72(4):1336-43.
1983: Hollister A S; FitzGerald G A; Nadeau J H; Robertson D
Acute reduction in human platelet alpha 2-adrenoreceptor affinity for agonist by endogenous and exogenous catecholamines.
The Journal of clinical investigation 1983;72(4):1498-505.
1983: Brash A R; Jackson E K; Saggese C A; Lawson J A; Oates J A; FitzGerald G A
Metabolic disposition of prostacyclin in humans.
The Journal of pharmacology and experimental therapeutics 1983;226(1):78-87.
1983: Feldman R D; Limbird L E; Nadeau J; FitzGerald G A; Robertson D; Wood A J
Dynamic regulation of leukocyte beta adrenergic receptor-agonist interactions by physiological changes in circulating catecholamines.
The Journal of clinical investigation 1983;72(1):164-70.
1983: FitzGerald G A; Pedersen A K; Patrono C
Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.
Circulation 1983;67(6):1174-7.
1983: FitzGerald G A; Oates J A; Hawiger J; Maas R L; Roberts L J; Lawson J A; Brash A R
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
The Journal of clinical investigation 1983;71(3):676-88.
1983: FitzGerald G A; Maas R L; Lawson J A; Oates J A; Roberts L J; Brash A R
Aspirin inhibits endogenous prostacyclin and thromboxane biosynthesis in man.
Advances in prostaglandin, thromboxane, and leukotriene research 1983;11():265-6.
1983: Brash A R; Jackson E K; Lawson J A; Branch R A; Oates J A; FitzGerald G A
Quantitative aspects of prostacyclin metabolism in humans.
Advances in prostaglandin, thromboxane, and leukotriene research 1983;11():119-22.
1982: Fitzgerald G A
Prostaglandins.
Irish medical journal 1982;75(5):167-71.
1982: Jackson E K; Goodman R P; Fitzgerald G A; Oates J A; Branch R A
Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects.
The Journal of pharmacology and experimental therapeutics 1982;221(1):183-7.
1982: Barnes P J; Fitzgerald G A; Dollery C T
Circadian variation in adrenergic responses in asthmatic subjects.
Clinical science (London, England : 1979) 1982;62(4):349-54.
1982: FitzGerald G A; Sherry S
Pharmacology and pharmacokinetics of platelet-active drugs under current clinical investigation.
Advances in prostaglandin, thromboxane, and leukotriene research 1982;10():107-72.
1981: FitzGerald G A; Brash A R; Falardeau P; Oates J A
Estimated rate of prostacyclin secretion into the circulation of normal man.
The Journal of clinical investigation 1981;68(5):1272-6.
1981: FitzGerald G A; Beggan M; Drury M I
Sources of referral, costs and length of hospital stay in a teaching hospital: impact of a day care facility.
Irish medical journal 1981;74(9):265-70.
1981: FitzGerald G A; Drury M I
Indices of cost for inpatients in a teaching hospital.
Irish medical journal 1981;74(9):262-4.
1981: Fitzgerald G A; Maas R L; Stein R; Oates J A; Roberts L J
Intravenous prostacyclin in thrombotic thrombocytopenic purpura.
Annals of internal medicine 1981;95(3):319-22.
1981: FitzGerald G A; Hossmann V; Dollery C T
Norepinephrine release in essential hypertension.
Clinical pharmacology and therapeutics 1981;30(2):164-71.
1981: Polish L B; Branch R A; Fitzgerald G A
Digitoxin-quinidine interaction: potentiation during administration of cimetidine.
Southern medical journal 1981;74(5):633-4.
1981: Hossman V; Heinen A; Auel H; FitzGerald G A
A randomized, placebo controlled trial of prostacyclin (PGI2) in peripheral arterial disease.
Thrombosis research 1981;22(4):481-90.
1981: Robertson R M; Robertson D; Roberts L J; Maas R L; FitzGerald G A; Friesinger G C; Oates J A
Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials.
The New England journal of medicine 1981;304(17):998-1003.
1981: FitzGerald G A; Watkins J; Dollery C T
Regulation of norepinephrine release by peripheral alpha 2-receptor stimulation.
Clinical pharmacology and therapeutics 1981;29(2):160-7.
1981: Hossmann V; FitzGerald G A; Dollery C T
Influence of hospitalization and placebo therapy on blood pressure and sympathetic function in essential hypertension.
Hypertension 1981;3(1):113-8.
1981: Fitzgerald G A; Robertson D; Wood A J
Beta-adrenoreceptor down-regulation by dynamic exercise and upright posture in man.
Transactions of the Association of American Physicians 1981;94():310-3.
1980: FitzGerald G A; Hossmann V; Hummerich W; Konrads A
The renin--kallikrein--prostaglandin system: plasma active and inactive renin and urinary kallikrein during prostacyclin infusion in man.
Prostaglandins and medicine 1980;5(6):445-56.
1980: Allolio B; Fitzgerald G A; Hipp F X; Hossmann V; Mies R; Winkelmann W
The effect of prostacyclin on pituitary hormone release.
British journal of clinical pharmacology 1980;10(6):626-7.
1980: Fitzgerald G A; Barnes P; Hamilton C A; Dollery C T
Circulating adrenaline and blood pressure: the metabolic effects and kinetics of infused adrenaline in man.
European journal of clinical investigation 1980;10(5):401-6.
1980: Fitzgerald G A; Hamilton C A; Jones D H; Reid J L
Erythrocytes catechol-O-methyltransferase activity and indices of sympathetic activity in man.
Clinical science (London, England : 1979) 1980;58(5):423-5.
1980: Hossmann V; Fitzgerald G A; Dollery C T
Circadian rhythm of baroreflex reactivity and adrenergic vascular response.
Cardiovascular research 1980;14(3):125-9.
1980: Brown M J; Dollery C T; Fitzgerald G A; Watkins J; Zamboulis C
No evidence for antagonism of clonidine by naloxone in man [proceedings]
British journal of clinical pharmacology 1980;9(3):302P.
1980: Barnes P; Dollery C T; Fitzgerald G A; Hamilton C A
The kinetics and concentration-effect relationships of circulating adrenaline in man [proceedings]
British journal of clinical pharmacology 1980;9(1):107P-108P.
1979: FitzGerald G A; Hossmann V; Hamilton C A; Reid J L; Davies D S; Dollery C T
Interindividual variation in kinetics of infused epinephrine.
Clinical pharmacology and therapeutics 1979;26(6):669-75.
1979: Miyamori I; FitzGerald G A; Brown M J; Lewis P J
Prostacyclin stimulates the renin angiotensin aldosterone system in man.
The Journal of clinical endocrinology and metabolism 1979;49(6):943-4.
1979: Hensby C N; Fitzgerald G A; Friedman L A; Lewis P J; Dollery C T
Measurement of 6-oxo-PGF1 alpha in human plasma using gas chromatography-mass spectrometry.
Prostaglandins 1979;18(5):731-6.
1979: Dollery C T; Fitzgerald G A; Watkins J
Pre and postsynaptic alpha-receptor agonists and the rate of release of noradrenaline in man [proceedings]
British journal of clinical pharmacology 1979;8(4):396P.
1979: FitzGerald G A
Neurogenic aspects of essential hypertension in man.
Irish journal of medical science 1979;148(9-10):280-9.
1979: Fitzgerald G A; Drury M I
One hundred days in a general medical/specialist unit--sources of referral and length of hospital stay.
Irish medical journal 1979;72(8):344-7.
1979: FitzGerald G A; Friedman L A; Miyamori I; O'Grady J; Lewis P J
A double blind placebo controlled crossover study of prostacyclin in man.
Life sciences 1979;25(8):665-72.
1979: McCarthy D; Fitzgerald G A; O'Connell L G; Waters J M; Watt D W; Stevens F M; McCarthy C F; Drury M I
Histocompatibility antigens and haemochromatosis in Ireland.
Irish journal of medical science 1979;148(5-6):168-72.
1979: Fitzgerald G A; Balcavage W X
Consequences dietary ethanol on permeability and respiration of mitochondria and liver ADH in young and aged rats.
Currents in alcoholism 1979;5():91-100.
1978: Fitzgerald G A; Drury M I
HLA identity in juvenile onset diabetes.
Irish journal of medical science 1978;147(12):430-4.
1978: FitzGerald G A
Hypertensive response to labetalol in phaeochromocytoma.
Lancet 1978;1(8076):1259.

Sign-in to see more